posted
Thursday, September 28 2006 8:32 AM, EST Lifeline Biotechnologies, Inc. Announces Revised Pay Date for Solos Endoscopy Stock Dividend to Shareholders of Record Market Wire "US Press Releases " RENO, NV -- (MARKET WIRE) -- 09/28/06 -- Lifeline Biotechnologies, Inc. (PINKSHEETS: LBTN) announced today that October 16, 2006 is the new date on which the stock dividend will be issued to their shareholders as of the record date, August 18, 2006 . Lifeline Biotechnologies' shareholders will receive approximately one share of SLSE stock for every 100 shares of LBTN stock owned by the record date. The final allocation is in the process of determination. Lifeline Biotechnologies and Solos Endoscopy recently announced, during a joint national teleconference, their plans to target the $20 billion minimally invasive medical market. Also, Lifeline Biotechnologies will continue its aggressive acquisition strategy focusing on alternative energy projects. Solos Endoscopy, Inc. announced, during the national teleconference, that the Company will be looking to grow their business rapidly in order to reach the $20 million to $30 million annual revenue levels Solos had experienced in the 1990s. Solos distributes its endoscopic products to over 3,000 hospitals worldwide. About Solos Endoscopy, Inc. : Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of disease and medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office. Additional information is available on the Company's website at: www.solosendoscopy.com. About Lifeline Biotechnologies, Inc. : Lifeline Biotechnologies develops and acquires undervalued companies which have innovative technology in the medical, nutraceutical, and energy industries, to increase the growth of the Company. Lifeline Biotechnologies continues to seek out and capitalize on emerging technologies that will change the medical, nutraceutical, and energy community. More information is available at the company's website: www.lbtn.com. Safe Harbor This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions. CONTACT:
Lifeline Biotechnologies, Inc. Investor Relations 407-884-0444 or 1-866-THE-APPLE
IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
